Trent G. Kamke - 09 Jun 2021 Form 4 Insider Report for LEMAITRE VASCULAR INC (LMAT)

Signature
/s/ Laurie A. Churchill, Attorney-in-fact
Issuer symbol
LMAT
Transactions as of
09 Jun 2021
Net transactions value
-$150,512
Form type
4
Filing time
11 Jun 2021, 20:48:30 UTC
Previous filing
07 Jun 2021
Next filing
16 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LMAT Common Stock Options Exercise $61,160 +1,954 +18% $31.30 12,606 09 Jun 2021 Direct F1
transaction LMAT Common Stock Options Exercise $48,004 +1,353 +11% $35.48 13,959 09 Jun 2021 Direct F1
transaction LMAT Common Stock Sale $175,782 -3,307 -24% $53.15 10,652 09 Jun 2021 Direct F2, F3
transaction LMAT Common Stock Options Exercise $81,317 +2,598 +24% $31.30 13,250 10 Jun 2021 Direct F1
transaction LMAT Common Stock Options Exercise $16,728 +710 +5.4% $23.56 13,960 10 Jun 2021 Direct F1
transaction LMAT Common Stock Sale $181,940 -3,308 -24% $55.00 10,652 10 Jun 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1,954 -25% $0.000000 6,005 09 Jun 2021 Common Stock 1,954 $31.30 Direct F4
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -1,353 -20% $0.000000 5,412 09 Jun 2021 Common Stock 1,353 $35.48 Direct F4
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -2,598 -43% $0.000000 3,407 10 Jun 2021 Common Stock 2,598 $31.30 Direct F4
transaction LMAT Stock Option (Right to Buy) Options Exercise $0 -710 -7.1% $0.000000 9,333 10 Jun 2021 Common Stock 710 $23.56 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2 This transaction was effected pursuant to a Rule 10b5-1 trading plan established by the Reporting Person.
F3 The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $52.02 to $53.71. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
F4 This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.